Xponance, Inc. Johnson & Johnson Transaction History

Xponance, Inc.

$9.68 Billion
Q2 2024

A detailed history of Xponance, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Xponance, Inc. holds 361,982 shares of JNJ stock, worth $60.1 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

361,982

Previous 369,059 1.92%

Holding current value

$60.1 Million

Previous $58.4 Million 9.38%

% of portfolio

0.55%

Previous 0.62%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $1.02 Million - $1.12 Million	-7,077 Reduced 1.92%	361,982 $52.9 Million
Q1 2024 May 13, 2024	BUY	$155.22 - $162.74 $3.82 Million - $4.01 Million	24,639 Added 7.15%	369,059 $58.4 Million
Q4 2023 Jan 31, 2024	BUY	$145.6 - $158.88 $4.4 Million - $4.8 Million	30,220 Added 9.62%	344,420 $54 Million
Q3 2023 Oct 23, 2023	SELL	$155.75 - $174.48 $2.18 Million - $2.44 Million	-13,966 Reduced 4.26%	314,200 $48.9 Million
Q2 2023 Jul 13, 2023	SELL	$154.35 - $166.11 $700,903 - $754,305	-4,541 Reduced 1.36%	328,166 $54.3 Million
Q1 2023 Apr 17, 2023	BUY	$151.05 - $180.26 $1.43 Million - $1.71 Million	9,465 Added 2.93%	332,707 $51.6 Million
Q4 2022 Jan 23, 2023	BUY	$160.2 - $179.79 $7.3 Million - $8.19 Million	45,567 Added 16.41%	323,242 $0
Q3 2022 Oct 24, 2022	BUY	$161.33 - $179.52 $6.9 Million - $7.68 Million	42,777 Added 18.21%	277,675 $45.4 Million
Q2 2022 Aug 02, 2022	SELL	$168.19 - $186.01 $765,937 - $847,089	-4,554 Reduced 1.9%	234,898 $41.7 Million
Q1 2022 Apr 20, 2022	BUY	$158.14 - $179.59 $481,852 - $547,210	3,047 Added 1.29%	239,452 $42.4 Million
Q4 2021 Jan 31, 2022	BUY	$155.93 - $173.01 $5.52 Million - $6.12 Million	35,381 Added 17.6%	236,405 $40.4 Million
Q3 2021 Nov 05, 2021	SELL	$161.5 - $179.47 $2.12 Million - $2.35 Million	-13,113 Reduced 6.12%	201,024 $32.5 Million
Q2 2021 Aug 12, 2021	SELL	$159.48 - $171.07 $4.24 Million - $4.55 Million	-26,588 Reduced 11.04%	214,137 $35.3 Million
Q1 2021 May 10, 2021	SELL	$153.07 - $170.48 $154,600 - $172,184	-1,010 Reduced 0.42%	240,725 $39.6 Million
Q4 2020 Feb 11, 2021	BUY	$137.11 - $157.38 $509,500 - $584,824	3,716 Added 1.56%	241,735 $38 Million
Q3 2020 Oct 26, 2020	SELL	$140.38 - $153.83 $2.96 Million - $3.25 Million	-21,103 Reduced 8.14%	238,019 $35.4 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $33.4 Million - $40.3 Million	259,122 New	259,122 $36.4 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account